Insiders Cyxone AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 17:00:00 28/06/2024 BST			5-day change	1st Jan Change
0.11 ^SEK	0.00%		-16.67%	+9.56%

05-14	Cyxone AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-22	Sweden's Cyxone Appoints New CEO	MT

Sweden's Cyxone Appoints New CEO	04-22	MT
Cyxone AB Announces Chief Executive Officer Changes	04-22	CI
Cyxone AB Announces Board Changes	30/05/23	CI
Cyxone AB Announces Board Resignations	26/04/23	CI
Cyxone Confirms Acting CEO with Permanent Appointment	13/12/22	MT
Cyxone AB Appoints Carl-Magnus Högerkorp as Permanent CEO	13/12/22	CI
Cyxone AB Announces That the Members of the Nomination Committee for Annual General Meeting 2023	08/11/22	CI
Cyxone Appoints Erika Samuelsson as Chief Development Officer	22/09/22	CI
Biotech Company Cyxone Appoints New Chief Development Officer	02/09/22	MT
Cyxone AB Appoints Erika Samuelsson as Chief Development Officer	02/09/22	CI
Swedish Drugmaker Cyxone CEO Departs	21/06/22	MT
Cyxone Announces Executive Changes	20/06/22	CI
Swedish Biotech Firm Cyxone's Chief Medical Officer Exits	23/02/22	MT
Cyxone Announces Resignation of Cornel Pater as Chief Medical Officer	23/02/22	CI
Cyxone AB Appoints Cornel Pater as New Chief Medical Officer	01/09/21	CI
Cyxone AB Appoints Ola Skanung as Senior Executive Advisor	09/06/21	CI
Cyxone AB Elects Peter Heinrich and Alejandra Mørk as New Board Members	03/06/21	CI
Cyxone AB Announces Executive Changes	25/05/21	CI
Christin Arrhenius Bokedal to Join Cyxone AB as Head of Development	08/09/20	CI
Cyxone AB Signs Agreement with Professor Rikard Holmdahl as Senior Scientific Advisor	08/07/20	CI

No results for this search